Interaction of the Poliovirus Receptor with Poliovirus

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2000 Jan 5

PMID 10618374

Citations 106

Authors

Y He

V D Bowman

S Mueller

C M Bator

J Bella

X Peng

T S Baker

E Wimmer

R J Kuhn

M G Rossmann

Affiliations

Soon will be listed here.

Abstract

The structure of the extracellular, three-domain poliovirus receptor (CD155) complexed with poliovirus (serotype 1) has been determined to 22-A resolution by means of cryo-electron microscopy and three-dimensional image-reconstruction techniques. Density corresponding to the receptor was isolated in a difference electron density map and fitted with known structures, homologous to those of the three individual CD155 Ig-like domains. The fit was confirmed by the location of carbohydrate moieties in the CD155 glycoprotein, the conserved properties of elbow angles in the structures of cell surface molecules with Ig-like folds, and the concordance with prior results of CD155 and poliovirus mutagenesis. CD155 binds in the poliovirus "canyon" and has a footprint similar to that of the intercellular adhesion molecule-1 receptor on human rhinoviruses. However, the orientation of the long, slender CD155 molecule relative to the poliovirus surface is quite different from the orientation of intercellular adhesion molecule-1 on rhinoviruses. In addition, the residues that provide specificity of recognition differ for the two receptors. The principal feature of receptor binding common to these two picornaviruses is the site in the canyon at which binding occurs. This site may be a trigger for initiation of the subsequent uncoating step required for viral infection.

Citing Articles

Antiviral Development for the Polio Endgame: Current Progress and Future Directions.

Xie H, Rhoden E, Liu H, Ogunsemowo F, Mainou B, Burke R Pathogens. 2024; 13(11).

PMID: 39599522 PMC: 11597170. DOI: 10.3390/pathogens13110969.

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?.

Devaux C, Pontarotti P, Levasseur A, Colson P, Raoult D Front Public Health. 2024; 11:1284337.

PMID: 38259741 PMC: 10801389. DOI: 10.3389/fpubh.2023.1284337.

A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes.

Charnesky A, Faust J, Lee H, Puligedda R, Goetschius D, DiNunno N Nat Commun. 2023; 14(1):6335.

PMID: 37816742 PMC: 10564760. DOI: 10.1038/s41467-023-41052-9.

CD96 as a Potential Immune Regulator in Cancers.

Feng S, Isayev O, Werner J, Bazhin A Int J Mol Sci. 2023; 24(2).

PMID: 36674817 PMC: 9866520. DOI: 10.3390/ijms24021303.

Molecular mechanism of antibody neutralization of coxsackievirus A16.

Zhang C, Liu C, Shi J, Wang Y, Xu C, Ye X Nat Commun. 2022; 13(1):7854.

PMID: 36543790 PMC: 9769477. DOI: 10.1038/s41467-022-35575-w.

References

Koike S, Ise I, Nomoto A . Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A. 1991; 88(10):4104-8. PMC: 51606. DOI: 10.1073/pnas.88.10.4104. View

Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N . The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 1990; 9(10):3217-24. PMC: 552052. DOI: 10.1002/j.1460-2075.1990.tb07520.x. View

Olson N, Kolatkar P, Oliveira M, Cheng R, Greve J, McClelland A . Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A. 1993; 90(2):507-11. PMC: 45692. DOI: 10.1073/pnas.90.2.507. View

Dryden K, Wang G, Yeager M, Nibert M, Coombs K, Furlong D . Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J Cell Biol. 1993; 122(5):1023-41. PMC: 2119633. DOI: 10.1083/jcb.122.5.1023. View

Morrison M, He Y, Wien M, Hogle J, Racaniello V . Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J Virol. 1994; 68(4):2578-88. PMC: 236735. DOI: 10.1128/JVI.68.4.2578-2588.1994. View

Bernhardt G, Harber J, Zibert A, deCrombrugghe M, Wimmer E . The poliovirus receptor: identification of domains and amino acid residues critical for virus binding. Virology. 1994; 203(2):344-56. DOI: 10.1006/viro.1994.1493. View

Colston E, Racaniello V . Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J. 1994; 13(24):5855-62. PMC: 395560. DOI: 10.1002/j.1460-2075.1994.tb06930.x. View

Rossmann M . Viral cell recognition and entry. Protein Sci. 1994; 3(10):1712-25. PMC: 2142612. DOI: 10.1002/pro.5560031010. View

Harber J, Bernhardt G, Lu H, Sgro J, Wimmer E . Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology. 1995; 214(2):559-70. DOI: 10.1006/viro.1995.0067. View

10.

Gromeier M, Alexander L, Wimmer E . Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A. 1996; 93(6):2370-5. PMC: 39803. DOI: 10.1073/pnas.93.6.2370. View

11.

Fuller S, Butcher S, Cheng R, Baker T . Three-dimensional reconstruction of icosahedral particles--the uncommon line. J Struct Biol. 1996; 116(1):48-55. DOI: 10.1006/jsbi.1996.0009. View

12.

Baker T, Cheng R . A model-based approach for determining orientations of biological macromolecules imaged by cryoelectron microscopy. J Struct Biol. 1996; 116(1):120-30. DOI: 10.1006/jsbi.1996.0020. View

13.

Curry S, Chow M, Hogle J . The poliovirus 135S particle is infectious. J Virol. 1996; 70(10):7125-31. PMC: 190765. DOI: 10.1128/JVI.70.10.7125-7131.1996. View

14.

Smith T, Chase E, Schmidt T, Olson N, Baker T . Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature. 1996; 383(6598):350-4. PMC: 4167671. DOI: 10.1038/383350a0. View

15.

Dove A, Racaniello V . Cold-adapted poliovirus mutants bypass a postentry replication block. J Virol. 1997; 71(6):4728-35. PMC: 191694. DOI: 10.1128/JVI.71.6.4728-4735.1997. View

16.

Chothia C, Jones E . The molecular structure of cell adhesion molecules. Annu Rev Biochem. 1997; 66:823-62. DOI: 10.1146/annurev.biochem.66.1.823. View

17.

Liao S, Racaniello V . Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors. J Virol. 1997; 71(12):9770-7. PMC: 230287. DOI: 10.1128/JVI.71.12.9770-9777.1997. View

18.

Bella J, Kolatkar P, Marlor C, Greve J, Rossmann M . The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci U S A. 1998; 95(8):4140-5. PMC: 22455. DOI: 10.1073/pnas.95.8.4140. View

19.

Arita M, Koike S, Aoki J, Horie H, Nomoto A . Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol. 1998; 72(5):3578-86. PMC: 109578. DOI: 10.1128/JVI.72.5.3578-3586.1998. View

20.

Lewis J, Bothner B, Smith T, Siuzdak G . Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci U S A. 1998; 95(12):6774-8. PMC: 22631. DOI: 10.1073/pnas.95.12.6774. View